Abstract:Introduction: Pulmonary tuberculosis (PTB) remains one of the deadliest infectious diseases. Understanding PTB immunity is of potential value for exploring immunotherapy for treating chemotherapy-resistant PTB. CD4 + CD25 + Foxp3 + regulatory T cells (Tregs) are key players that impair immune responses to Mycobacteria tuberculosis (MTB). Currently, the intrinsic factors governing Treg expansion and influencing the immunosuppressive attributes of Tregs in PTB patients are far from clear. Methods: Here, we employed flow cytometry to determine the frequency of Tregs and the expression of B and T lymphocyte attenuator (BTLA) and its ligand, herpesvirus entry mediator (HVEM), on Tregs in patients with active PTB. Furthermore, the expression of conventional T cells and of programmed death-ligand 1 (PD-L1) and programmed death-1 (PD-1) on Tregs in patients with active PTB was determined. We then examined the characteristics of BTLA/HVEM expression and its correlation with Treg frequency and PD-L1 and PD-1 expression on Tregs in PTB patients. Results: The frequency of Tregs was increased in PTB patients and it had a relevance to PTB progression. Intriguingly, the axis of cosignal molecules, BTLA and HVEM, were both downregulated on the Tregs of PTB patients compared with healthy controls (HCs), which was the opposite of their upregulation on conventional T cells. Unexpectedly, their expression levels were positively correlated with the frequency of Tregs, respectively. These seemingly contradictory results may be interpreted as follows: the downregulation of BTLA and HVEM may alleviate BTLA/HVEM cis -interaction-mediated coinhibitory signals pressing on naïve Tregs, helping their activation, while the BTLA/HVEM axis on effector Tregs induces a costimulatory signal, promoting their expansion. Certainly, the mechanism underlying such complex effects remains to be explored. Additionally, PD-L1 and PD-1, regarded as two of the markers characterizing the immunosuppressive attributes and differentiation potential of Tregs, were upregulated on the Tregs of PTB patients. Further analysis revealed that the expression levels of BTLA and HVEM were positively correlated with the frequency of PD-1 + Tregs and PD-L1 + Tregs, respectively. Conclusion: Our study illuminated distinct characteristics of BTLA/HVEM axis expression on Tregs and uncovered its impact on the expansion and attributes of Tregs in patients with active PTB. Therefore, blockade of the BTLA/HVEM axis may be a promising potential pathway to reduce Treg expansion for the improvement of anti-MTB immune responses.

Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis

Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis

Elevated Expression of Tim-3 on CD8 T Cells Correlates with Disease Severity of Pulmonary Tuberculosis.

CD11b(+) Dendritic Cell-Mediated Anti-Mycobacterium Tuberculosis Th1 Activation is Counterregulated by CD103(+) Dendritic Cells Via IL-10

Tim-3-Expressing Cd4(+) And Cd8(+) T Cells In Human Tuberculosis (Tb) Exhibit Polarized Effector Memory Phenotypes And Stronger Anti-Tb Effector Functions

Distribution of Memory T Cells in CD4+/CD8+ Tim-3+/Tim-3- T Cell Population in PBMCs from Patients with Active Pulmonary Tuberculosis

STAT3 Regulation of Mtb-specific T Cell Function in Active Pulmonary Tuberculosis Patients.

Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment

Single-cell transcriptome sequencing reveals altered peripheral blood immune cells in patients with severe tuberculosis

BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in Mycobacterium tuberculosis Infection

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

Tim-3 Expression is Induced by Mycobacterial Antigens and Identifies Tissue-Resident Subsets of MAIT Cells from Patients with Tuberculosis

The regulation and potential role of interleukin-32 in tuberculous pleural effusion

TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection

Elevated expression of Tim-3 in CD 56 dimCD 16 + NK cells correlates with disease severity of pulmonary tuberculosis

Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells Suppress Mycobacterium Tuberculosis Immunity in Patients with Active Disease

PD-1/PD-L pathway inhibits M . tb -specific CD4 + T-cell functions and phagocytosis of macrophages in active tuberculosis

Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis

Selective Destruction of Interleukin 23-Induced Expansion of a Major Antigen-Specific γδ T-Cell Subset in Patients With Tuberculosis.

The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity

TLT2 Suppresses Th1 Response by Promoting IL-6 Production in Monocyte Through JAK/STAT3 Signal Pathway in Tuberculosis.